Margaret Danielle Weiss, M.D.,C.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 36 | 2024 | 3708 | 4.660 |
Why?
|
| Methylphenidate | 7 | 2021 | 488 | 2.870 |
Why?
|
| Central Nervous System Stimulants | 10 | 2024 | 1177 | 2.630 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2023 | 6019 | 1.440 |
Why?
|
| School Nursing | 1 | 2023 | 33 | 0.850 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2022 | 306 | 0.750 |
Why?
|
| Delayed-Action Preparations | 8 | 2021 | 962 | 0.730 |
Why?
|
| Translations | 2 | 2018 | 81 | 0.700 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 1509 | 0.540 |
Why?
|
| Psychometrics | 4 | 2018 | 3065 | 0.530 |
Why?
|
| Drug Tolerance | 1 | 2017 | 367 | 0.520 |
Why?
|
| Drug Design | 1 | 2020 | 1048 | 0.500 |
Why?
|
| Melatonin | 4 | 2010 | 669 | 0.490 |
Why?
|
| Family Relations | 1 | 2017 | 317 | 0.480 |
Why?
|
| Autistic Disorder | 1 | 2024 | 1220 | 0.480 |
Why?
|
| Fathers | 1 | 2017 | 376 | 0.460 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 460 | 0.430 |
Why?
|
| Child Behavior | 1 | 2019 | 847 | 0.430 |
Why?
|
| Reward | 2 | 2020 | 971 | 0.430 |
Why?
|
| Remission Induction | 1 | 2018 | 2397 | 0.410 |
Why?
|
| Checklist | 1 | 2019 | 827 | 0.390 |
Why?
|
| Sleep | 4 | 2022 | 4768 | 0.390 |
Why?
|
| Amphetamines | 2 | 2010 | 143 | 0.390 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2021 | 1081 | 0.390 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2021 | 10766 | 0.380 |
Why?
|
| Central Nervous System Depressants | 3 | 2010 | 164 | 0.380 |
Why?
|
| Parenting | 1 | 2017 | 701 | 0.370 |
Why?
|
| Terminology as Topic | 1 | 2017 | 1530 | 0.350 |
Why?
|
| Quality of Life | 7 | 2022 | 13367 | 0.350 |
Why?
|
| Double-Blind Method | 9 | 2021 | 12341 | 0.330 |
Why?
|
| Mothers | 2 | 2017 | 2198 | 0.320 |
Why?
|
| Attention | 1 | 2019 | 2396 | 0.310 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2008 | 196 | 0.310 |
Why?
|
| Family Therapy | 1 | 2009 | 215 | 0.290 |
Why?
|
| Community Mental Health Centers | 1 | 2007 | 93 | 0.280 |
Why?
|
| Telemedicine | 1 | 2023 | 3052 | 0.250 |
Why?
|
| Self Report | 1 | 2016 | 3725 | 0.250 |
Why?
|
| Adolescent | 14 | 2024 | 88324 | 0.240 |
Why?
|
| Child | 22 | 2024 | 80156 | 0.230 |
Why?
|
| Propylamines | 4 | 2009 | 161 | 0.230 |
Why?
|
| Adrenergic Uptake Inhibitors | 3 | 2009 | 186 | 0.210 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2008 | 600 | 0.210 |
Why?
|
| Mental Disorders | 3 | 2019 | 6845 | 0.200 |
Why?
|
| Comorbidity | 7 | 2022 | 10508 | 0.200 |
Why?
|
| Humans | 42 | 2024 | 761572 | 0.190 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 2319 | 0.180 |
Why?
|
| Southeastern United States | 1 | 2019 | 91 | 0.160 |
Why?
|
| Caregivers | 2 | 2009 | 2238 | 0.140 |
Why?
|
| Guanfacine | 2 | 2015 | 51 | 0.140 |
Why?
|
| Treatment Outcome | 12 | 2021 | 64684 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2007 | 2775 | 0.130 |
Why?
|
| Parents | 2 | 2023 | 3563 | 0.130 |
Why?
|
| ROC Curve | 1 | 2023 | 3579 | 0.130 |
Why?
|
| Iran | 1 | 2018 | 737 | 0.130 |
Why?
|
| Male | 24 | 2023 | 360842 | 0.130 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 763 | 0.120 |
Why?
|
| Language | 1 | 2024 | 1540 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 2 | 2014 | 999 | 0.120 |
Why?
|
| Adult | 15 | 2021 | 221203 | 0.120 |
Why?
|
| Female | 23 | 2023 | 392686 | 0.120 |
Why?
|
| Turkey | 1 | 2014 | 254 | 0.110 |
Why?
|
| Intelligence | 1 | 2019 | 924 | 0.110 |
Why?
|
| Executive Function | 1 | 2022 | 1392 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20099 | 0.110 |
Why?
|
| Students | 1 | 2023 | 1741 | 0.100 |
Why?
|
| Reaction Time | 1 | 2019 | 2089 | 0.100 |
Why?
|
| Cross-Over Studies | 3 | 2008 | 2079 | 0.100 |
Why?
|
| Japan | 1 | 2016 | 1378 | 0.100 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2011 | 1988 | 0.090 |
Why?
|
| Histamine Antagonists | 1 | 2010 | 92 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 888 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2023 | 3600 | 0.090 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2010 | 177 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8002 | 0.080 |
Why?
|
| Mental Health | 2 | 2023 | 3250 | 0.080 |
Why?
|
| Diet Therapy | 1 | 2010 | 151 | 0.080 |
Why?
|
| Motivation | 1 | 2019 | 2006 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2226 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 3358 | 0.080 |
Why?
|
| Drug Administration Schedule | 3 | 2015 | 4853 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15843 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2014 | 6228 | 0.080 |
Why?
|
| Child Care | 1 | 2008 | 124 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2011 | 829 | 0.070 |
Why?
|
| Inpatients | 1 | 2019 | 2548 | 0.070 |
Why?
|
| Community Mental Health Services | 1 | 2010 | 392 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 5440 | 0.070 |
Why?
|
| Sex Factors | 2 | 2011 | 10553 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7391 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 7054 | 0.070 |
Why?
|
| Logistic Models | 2 | 2019 | 13255 | 0.060 |
Why?
|
| Alcohol-Related Disorders | 1 | 2008 | 238 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 59255 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2010 | 879 | 0.060 |
Why?
|
| Aging | 1 | 2004 | 8711 | 0.060 |
Why?
|
| Age Factors | 2 | 2011 | 18398 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2006 | 412 | 0.050 |
Why?
|
| Education | 1 | 2006 | 537 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8656 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 22176 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 2421 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26127 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39107 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6344 | 0.050 |
Why?
|
| Research | 1 | 2009 | 1982 | 0.040 |
Why?
|
| Arousal | 1 | 2006 | 1166 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2014 | 42230 | 0.040 |
Why?
|
| Health Education | 1 | 2006 | 1052 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2897 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 2629 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 628 | 0.040 |
Why?
|
| Drug Costs | 1 | 2006 | 1183 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 39970 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 3461 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8528 | 0.030 |
Why?
|
| Health Status | 1 | 2010 | 4077 | 0.030 |
Why?
|
| Age of Onset | 1 | 2004 | 3306 | 0.030 |
Why?
|
| Patient Participation | 1 | 2006 | 1445 | 0.030 |
Why?
|
| Middle Aged | 6 | 2016 | 220920 | 0.030 |
Why?
|
| Aged | 4 | 2016 | 169310 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2006 | 1936 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2006 | 2690 | 0.030 |
Why?
|
| Risk Factors | 3 | 2021 | 74213 | 0.030 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 91 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 2576 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 3123 | 0.030 |
Why?
|
| Social Support | 1 | 2004 | 2171 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 3249 | 0.030 |
Why?
|
| Canada | 1 | 2015 | 2122 | 0.020 |
Why?
|
| Research Design | 1 | 2006 | 6180 | 0.020 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 346 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 168467 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12975 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14666 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2606 | 0.020 |
Why?
|
| Teaching | 1 | 2014 | 1170 | 0.020 |
Why?
|
| Algorithms | 1 | 2006 | 14032 | 0.020 |
Why?
|
| Clonidine | 1 | 2006 | 169 | 0.020 |
Why?
|
| New York | 1 | 2007 | 874 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2007 | 1019 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 761 | 0.010 |
Why?
|
| Bupropion | 1 | 2006 | 304 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 2006 | 265 | 0.010 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2006 | 432 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2007 | 1596 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10721 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2007 | 2358 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7827 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 4016 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2006 | 916 | 0.010 |
Why?
|
| Physician's Role | 1 | 2006 | 917 | 0.010 |
Why?
|
| Health Surveys | 1 | 2007 | 4061 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 4028 | 0.010 |
Why?
|
| Pediatrics | 1 | 2008 | 3589 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4481 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10212 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2006 | 4686 | 0.010 |
Why?
|
| United States | 1 | 2015 | 72335 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2008 | 23996 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 36192 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 54426 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2009 | 80646 | 0.000 |
Why?
|